ZS Whitepapers, Videos and Case Studies

Medtech Analytics: Finding the Right Data Fit

Blogs

How can you sort through so many medtech data options to find the best source? And once you find one, how do you assess whether it’s worth the investment?

Is Data Science the Treatment for Inefficiencies in Clinical Trial Operations?

Whitepaper

Here’s how data science can transform the way that life sciences companies find the right patient population.

Why Oncology Marketers Need to Go Back to Basics

Blogs

The biggest data engine, the strongest predictive algorithms and the slickest mobile app can't help drive success for the brand if there’s no clear strategic direction. It's time to go back to the oncology marketing basics.

Airplane Bathrooms Are Getting Even Smaller. Where Does the Squeeze End?

Blogs

Tiny airplane bathrooms are shrinking even more. Will the trend end?

If We Pull the Plug on Drug Rebates, Can We Finally Focus on Value?

Blogs

Doing away with the opaque system of discounts between payers and drugmakers could be the incentive that pharma companies need to evolve their own promotional practices, moving the conversation away from price and focusing, instead, on value and outcomes.

Medtech Companies Need to be Solutions-Oriented, not Product-Driven

Blogs

Medtech companies need to fundamentally rethink what it means to bring value to customers. Here's why.

New ZS Research Shows How MedTech Can Be Better Partners For IDNS

Infographics

Medtech companies need to rethink what it means to bring value to IDNs. New ZS research uncovers 4 focus areas.

Can the FDA’s Biosimilars Action Plan Change the Game for Biosimilars in the U.S.?

Blogs

Biosimilars have struggled to penetrate the U.S. market, so the FDA has developed the Biosimilars Action Plan (BAP) to strike a balance between innovation and competition in the U.S. biologics market. The BAP is poised to affect biosimilar developers, originators and prescribers. Here’s how.

The Profit Equation: Using Analytics to Solve for Growth in Medtech

Blogs

Advanced analytics can fuel medtech’s engines of innovation and performance, and enable profitable growth.

Don't Overlook Regional Airports' Importance

Blogs

Here’s why regional airports matter – and what this means for United’s expansion strategy.

How Do You Energize Your Sales Force?

Blogs

Is your sales force energized? Here’s how to find out.

The CVS/Aetna Merger Got the Greenlight, but Pharma Is Stuck at an Imaginary Red

Blogs

With the U.S. Department of Justice’s stamp of approval, the CVS/Aetna partnership is one step closer to taking aim at urgent care centers and hospitals by leveraging the drug chain’s retail locations and using data and technology to improve consumer health and wellness.

US Biosimilar Landscape: Multi-Stakeholder Analysis

Article

This newly released ZS report assesses key stakeholder perspective on biosimilar landscape. Read the report for answers around few burning questions in the biosimilar space.

How COAPT’s ‘All or Nothing’ Trial Design Is Making Sense of a Messy Disease

Blogs

How Abbott's all or nothing’ trial design, COAPT, is making sense of functional mitral regurgitation.

To Be Truly Effective, Key Account Management Needs Better Technology

Blogs

How better technology can improve key account management.

Americas

Asia

Europe

Insights

Sales

Marketing

Innovations

Regions

Content Type

Displaying 828 result(s)

INSIGHTS

Featured Blogs

Services

Insights

About

Careers